Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

272

HTML

2303

Figures (1-5)

284

Sum=2859

Apr 14, 2009 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Apr 14, 2009; 15(14): 1744-1750
Published online Apr 14, 2009. doi: 10.3748/wjg.15.1744

Full Size Figure Download Figure

Figure 2 Robust efficacy of rVBMDMP against HepG2 xenografts in nude mice (mean ± SD, n = 6). ^aP < 0.05, ^bP < 0.01 vs NS.

Citation: Wu YH, Cao JG, Xiang HL, Xia H, Qin Y, Huang AJ, Xiao D, Xu F. Recombinant vascular basement-membrane-derived multifunctional peptide inhibits angiogenesis and growth of hepatocellular carcinoma. World J Gastroenterol 2009; 15(14): 1744-1750
URL: https://www.wjgnet.com/1007-9327/full/v15/i14/1744.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1744